Cellular Intelligence
Building a future where biology is design
Boston, United States · Founded 2023 · $52.3M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- cellularintelligence.com
- Total Funding
- $52.3M
- Last Round
- $47.0M Series AMay 2025
- Rounds
- 2
About
Founded in late 2023, Somite AI developed an AI platform called AlphaStem targeting cell therapy and drug development. In 2026 the company rebranded as Cellular Intelligence, building the first universal virtual cell-signaling model to decode and control cellular behavior. Backed by Khosla Ventures, Chan Zuckerberg Initiative, and AMD Ventures, the company has raised over $100M with scientific co-founders from Harvard Medical School and MIT.
Summary
Cellular Intelligence is a Healthcare company based in Boston, United States, founded in 2023. It has raised $52.3M in total across 2 rounds, most recently a $47.0M Series A round in May 2025. Investors include Khosla Ventures, SciFi VC and Chan Zuckerberg Initiative.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company